SCHEMBL9987804

SCHEMBL9987804

COCC(c1cc2[nH]cc(-c3cc4c(Cl)ccnc4[nH]3)c2nc1C(COC)N1CCOCC1)N1CCOCC1

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CDK9 P50750 4/20 0.35
CDC7 O00311 2/20 0.35
PIM1 P11309 2/20 0.35
CDK2 P24941 2/20 0.35
CDK1 P06493 1/20 0.35
CASP3 P42574 1/20 0.35
CASP7 P55210 1/20 0.35
CAMKK2 Q96RR4 10/20 0.34
MAPK8 P45983 8/20 0.33
CHUK O15111 7/20 0.33
INSR P06213 4/20 0.33
CCNT1 O60563 2/20 0.33
TBK1 Q9UHD2 2/20 0.33
EGFR P00533 1/20 0.33
EIF2AK2 P19525 1/20 0.32
ROCK2 O75116 1/20 0.32
MAP4K4 O95819 1/20 0.32
PRKACA P17612 1/20 0.32
GSK3B P49841 1/20 0.32
HIPK2 Q9H2X6 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9987774 0.86 EGFR (0.35) CDK9CDK2CDK1CASP3CASP7
SCHEMBL9987597 0.81 LRRK2 (0.35) EGFR
SCHEMBL2990264 0.70 EGFR (0.38) CDK9CDC7PIM1CDK1CAMKK2
SCHEMBL9987808 0.67 TBK1 (0.39) CDK9CDC7PIM1CDK2CDK1
SCHEMBL2987587 0.65 CDK9 (0.45) CDK9CDK2CDK1CASP3CASP7
SCHEMBL5538584 0.64 CDK9 (0.40) CDK9CDC7PIM1CDK1CAMKK2
SCHEMBL1779702 0.63 MAP3K14 (0.52) CDK9CCNT1GSK3BCLK4
SCHEMBL31240681 0.63 CDK9 (0.50) CDK9CDC7PIM1CDK2CCNT1
SCHEMBL2996608 0.62 GRIN2B (0.43) CDK9CDK2CDK1CASP3CASP7
SCHEMBL1748609 0.62 CDK9 (0.47) CDK9CDK2CDK1CASP3CASP7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1799691-B1 NOVEL BIS-AZAINDOLE DERIVATIVES, PREPARATION AND PHARMACEUTICAL USE THEREOF AS KINASE INHIBITORS AVENTIS PHARMA SA (FR) 2011-12-21 EP claimed